Journal profile · IMMUNOLOGY

Case Reports in Immunology

ISSN 2090-6609 · eISSN 2090-6617 · John Wiley & Sons, Inc. · USA

Case Reports in Immunology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.9 (journal website); fully open access; APC about USD 3,110; median 121 days to acceptance (36 articles, last 24 months); acceptance rate 29% (journal website); 11 articles in 2025; indexed in ESCI and Scopus.

Impact factor0.9From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time121 daysMedian, submission to acceptance · 36 articles, last 24 months · Crossref
APCUSD 3,110Fully open access
Acceptance29%From the journal's website
Articles per year112025 · OpenAlex count

Scope

Aims, scope and focus

Case Reports in Immunology is published by John Wiley & Sons, Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction and IgG4-Related and Inflammatory Diseases, together about 33.2% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)

Case Reports in Immunology is an open access journal publishing case reports and case series related to allergies, immunodeficiencies, autoimmune diseases, immune disorders, cancer immunology and transplantation immunology.

From the journal's Aims & Scope

Research area (LetPub): IMMUNOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Immunodeficiency and Autoimmune DisordersImmunology and Microbiology21.5%
  2. Immune Cell Function and InteractionImmunology and Microbiology7%
  3. IgG4-Related and Inflammatory DiseasesMedicine4.7%
  4. Blood disorders and treatmentsBiochemistry, Genetics and Molecular Biology4.7%
  5. Vasculitis and related conditionsMedicine4.3%
  6. Systemic Lupus Erythematosus ResearchMedicine3.9%
  7. Drug-Induced Adverse ReactionsMedicine3.9%
  8. Autoimmune and Inflammatory Disorders ResearchMedicine3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorImmunologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorImmunologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
0.9Publisher website ·
CiteScore 2026-06
2.2LetPub ·
CiteScore (publisher)
2.2Publisher website ·
SJR 2026-06
0.26LetPub ·
SNIP 2026-06
0.51LetPub ·
h-index
16OpenAlex ·
i10-index
30OpenAlex ·
2-year mean citedness
0.89OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
10LetPub ·

Articles by year OpenAlex count · 185 in total · the current year is incomplete

YearArticlesOpen accessCitations
202627271
2025111110
20249931
20237714
2022131364
2021141458

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

121 daysMedian, submission to acceptance · P25–P75 94 days – 239 days

Acceptance to online
median 27 days (36 articles)
Submission to online
median 171 days
Sample
36 articles with submission and acceptance dates (33 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 15 weeksLetPub ·
Acceptance rate (publisher)
29%Publisher website ·
Submission to first decision
101 daysPublisher website ·
Submission to publication (journal-reported)
about 15 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 3,110 / GBP 2,080 / EUR 2,440YesCC BY
OpenAlexUSD 790 / EUR 680 / GBP 580——
LetPubUSD 725Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare2 items from the author guidelines
Abstract
≤ 300 words
Reference style
Chicago
Publisher website · model-extracted, each line checked against the text
Article types accepted2
  1. case reportCase ReportLength not stated
  2. case seriesCase SeriesLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
Authorship Title and authorship information

The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…

Source ↗Publisher website ·
Conflicts of interest Conflicts of interest

Max 3 manuscripts under review per author. Model summary

Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…

Source ↗Publisher website ·
Data availability Data availability

Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.

Source ↗Publisher website ·
License & copyright Copyright and permissions

Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…

Source ↗Publisher website ·
Open access

Copyright retained by authors; open access articles under CC BY. Model summary

Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Source ↗Publisher website ·
Peer review Peer review

Single-anonymized peer review model for applicable article types. Model summary

The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…

Source ↗Publisher website ·
Preprints Preprints

Preprint servers accepted. Model summary

The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.

Source ↗Publisher website ·
Trial registration / reporting guidelines Reporting guidelines

Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
John Wiley & Sons, Inc.
Country or region
USA
Language
English
ISSN
2090-6609
Electronic ISSN
2090-6617
Official links

FAQ

Frequently asked questions about Case Reports in Immunology

What CAS zone is Case Reports in Immunology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Case Reports in Immunology is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Case Reports in Immunology?

The journal's website gives an impact factor of 0.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.2, h-index 16.

How long does peer review take at Case Reports in Immunology?

Based on the dates recorded on 36 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 121 days (interquartile range 94–239 days); authors report an average review time of about 15 weeks; the journal's website gives an acceptance rate of 29%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Case Reports in Immunology?

According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index Case Reports in Immunology?

According to LetPub and DOAJ records, Case Reports in Immunology is indexed in ESCI, Scopus and DOAJ.

Is Case Reports in Immunology open access, and what is the APC?

Case Reports in Immunology is a fully open-access journal. APC about USD 3,110.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .